Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chao-Hui Sylvia Huang has a total of 236 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Early palliative care for African American and rural-dwelling advanced cancer family caregivers: long-term outcomes

    by J Nicholas Odom, Andres Azuero, Richard A Taylor, Jennifer Young Pierce, Chelsea L McGowen, Maria Pisu, Gabrielle Rocque, Rhiannon D Reed, Rachel Wells, Shena Gazaway, et al.

    Background: African American and rural-dwelling family caregivers of patients with advanced cancer may face structural, geographic, transportation, and access barriers to supportive care. Evidence is limited regarding the long-term effects of early palliative care interventions designed for these populations. Methods: We examined 36-week and 48-week outcome data from 222 caregivers and 165 patients who participated in a single-blind, multisite randomized clinical trial (intervention vs usual care) of a lay-coach-led, caregiver-focused early palliative care intervention ENABLE Cornerstone (January 2020-November 2025). Caregiver and patient anxiety and depressive symptoms (Hospital Anxiety and Depression Scale [HADS]), quality of life (QOL) (PROMIS Global Health 10), and caregiver burden (Montgomery-Borgatta Caregiver Burden scales [MBCB]) at 36 and 48 weeks were examined using baseline-constrained linear mixed-effects models with participant and intervention-coach random effects. Results: Intervention caregivers reported lower demand burden compared with usual care at 36 weeks (mean [SE] difference = −1.54 [0.52]; Cohen’s d = −0.41 [95% CI = −0.68 to −0.13]; adjusted P = .03). Intervention patients demonstrated significantly lower depressive symptoms at 36 weeks (mean [SE] difference = −1.53 [0.61]; Cohen’s d = −0.38 [95% CI = −0.67 to −0.08]; adjusted P = .048) and better physical quality of life at 48 weeks (mean [SE] difference = 3.93 [1.38]; Cohen’s d = 0.46 [95% CI = 0.14 to 0.78]; adjusted P = .02). Conclusions: This caregiver-focused early palliative care intervention produced significant long-term patient benefits in a trial enrolling African American and rural-dwelling caregivers, including lower patient depressive symptoms and better physical QOL. Caregiver effects were more limited, although demand burden improved. These findings support scalable caregiver-focused palliative care strategies for populations facing barriers to specialty supportive care. ClinicalTrials.gov identifier: NCT04318886

  • My Heart Will Go On: Caregiver Experiences of a Legacy Intervention in Acute Palliative Care

    by Korijna Valenti, Mary Cleveland, Kim Hamrick, Jasmine Vickers, Macy L. Stockdill, Jennifer Hicks, Rodney O. Tucker, Chao-Hui Sylvia Huang


  • Open Access

    Patient Perspectives on Technological Barriers and Implementation Strategies Leveraged During a Real-World Remote Symptom Monitoring Program

    by Tanvi V. Padalkar, Nicole L. Henderson, D'AMbra N. Dent, Emma Hendrix, Catherine Smith, Chao-Hui Sylvia Huang, Tara Kaufmann, Chelsea McGowan, Jennifer Young Pierce, Stacey A. Ingram, et al.

    PURPOSE: Remote symptom monitoring (RSM) using electronic patient-reported outcomes leverages digital technologies to gather real-time information on patient experiences for symptom management. This study reports a formative evaluation of technology-related barriers encountered by patients participating in RSM and implementation strategies used to address those barriers in real-world, large-scale RSM implementations. METHODS: Purposive sampling was conducted to recruit patients diagnosed with cancer and participating in RSM at the University of Alabama at Birmingham and USA Health Mitchell Cancer Institute for semi-structured interviews. Interviews were coded to identify technology-related barriers using a constant comparative method. Expert Recommendations for Implementing Change list was used to address the barriers to optimize RSM implementation. Barrier-associated themes from the interviews were mapped to implementation strategies. RESULTS: Forty participants age 24-77 years, half of whom were 60 years or older, were interviewed from December 2021 to February 2024. Three barrier themes relevant to technology utilization in RSM were identified: (1) accessibility concerns , (2) digital health literacy , and (3) user interface challenges . Themes were mapped to the implementation strategies as identified by the implementation team. Eight total implementation strategies were used to address these technology barriers: (1) assess for readiness and identify barriers and facilitators, (2) obtain and use patients/consumers and family/caregiver feedback, (3) involve patients/consumers and family members/caregivers, (4) access new funding, (5) change physical structure and equipment, (6) centralize technical assistance, (7) prepare patients/consumers to be active participants, and (8) intervene with patients/consumers to enhance uptake and adherence. CONCLUSION: Technology-related barriers may limit the uptake of RSM by patients. Addressing these barriers through multimodel assessment and intervention strategies is crucial to ensuring successful implementation of RSM in real-world settings.


  • Open Access

    Qualitative Study of Health Care Team Perception of the Benefits and Limitations of Remote Symptom Monitoring

    by Emma K. Hendrix, Nicole L. Henderson, Tanvi V. Padalkar, Tara Kaufmann, Stacey A. Ingram, D'AMbra N. Dent, Chao-Hui Sylvia Huang, J. Nicholas Odom, Bryan J. Weiner, Doris Howell, et al.

    PURPOSE: Remote symptom monitoring (RSM) using electronic patient-reported outcomes (ePROS) connects patients and health care teams between appointments. Patient-perceived benefits and drawbacks of RSM are well-known, but health care team members' perceptions are less clear. METHODS: Health care team members from the University of Alabama at Birmingham and the University of South Alabama Health Mitchell Cancer Institute participated in semi-structured qualitative interviews to explore their experiences and perspectives on RSM benefits and limitations. Interviews were audio-recorded, transcribed, and analyzed inductively using NVivo software to identify recurring themes and exemplary quotes. RESULTS: Thirty oncology health care team members, including physicians (n = 9), nurse practitioners (n = 2), nurses (n = 8), nonclinical navigators (n = 7), and administrators (n = 4), were interviewed. Findings were organized into five major themes: three benefits ( Proactive, Improved Patient-Health Care Team Relationship , and Patient Engagement and Symptom Reporting ) and two limitations ( Health Care Team-Perceived Limited Patient Buy-In or Awareness and Workload and Workflow Issues ). Health care team members perceived that RSM improved their ability to support patients and the quality of care delivered to patients by promoting proactive management, strengthening the patient-health care team relationship, and engaging patients in symptom reporting. Despite positive perceptions, health care team members also voiced drawbacks of RSM related to the lack of patient buy-in or awareness and increased workload and disrupted workflow. CONCLUSION: Although health care team members recognized the benefits of RSM as a standard of care, future work is necessary to address identified limitations to support wide-scale implementation of RSM in oncology practices.


  • Open Access

    Designing and Developing Interprofessional Learning Experiences in Palliative Care: A Collaborative Workshop Approach

    by Carolyn Kezar, Justine McGiboney, Michael D. Barnett, Richard Taylor, Rebecca Edwards, Ella H. Bowman, Elizabeth McAlister, Moneka A. Thompson, Tara Schapmire, Chao-Hui Sylvia Huang

    Background: Team-based care is vital in palliative care, but there is limited interprofessional education (IPE) among health care providers, leading to siloed learning. This project addresses this gap by developing a workshop focused on the active dying process, promoting shared competencies among palliative medicine, geriatrics, nursing, and psychology subspecialty learners. Objective: We aimed to design, implement, and evaluate an Interprofessional Education Exchange (IPEX) Death and Dying workshop to foster interdisciplinary collaboration and improve participants’ comfort with palliative care competencies. Design: A full-day, case-based workshop was developed using the Analysis, Design, Development, Implementation, Evaluation model, emphasizing experiential and collaborative learning. Setting/Subjects: Two workshops were held at a tertiary southeastern academic university in the United States (US) in 2022 (cohort 1) and 2023 (cohort 2). A total of 25 participants, including palliative medicine fellows, geriatric medicine fellows, advanced nurse practitioner students, and psychology residents, completed the workshops. Measurements: Participants’ comfort with palliative care competencies, perceptions of interprofessional collaboration, and qualitative feedback were assessed using post-workshop surveys. Results: Participants’ comfort in providing anticipatory guidance, addressing spiritual distress, and supporting grief and bereavement improved. Interprofessional collaboration and professional growth, particularly in communication and understanding each other’s roles and responsibilities in caring for the actively dying, also increased. Conclusions: The collaborative IPEX Death and Dying workshop has been shown to enhance competencies and foster interprofessional collaboration among palliative care subspecialty learners across four disciplines. This model holds potential for broader implementation across health care settings to improve care for the seriously ill patients.


  • Open Access

    Understanding Multi-Level Factors Impacting Digital Health Literacy in the Deep South of the United States

    by Tanvi V. Padalkar, Keyonsis Hildreth, Gabrielle B. Rocque, Stacey A. Ingram, Omari Whitlow, Dan Chu, Connie C. Shao, Courtney P. Williams, Claudia M. Hardy, Chao-Hui Sylvia Huang, et al.

    As healthcare and health services become increasingly digitized, individuals with low digital health literacy (DHL) may experience inequitable care and outcomes. We explored factors impacting DHL and recommendations for improvement from community health coordinators and advisors (CHAs) in Alabama and Mississippi in United States. Semi-structured interviews were conducted with CHAs to gather insights on their perspectives on and experiences with DHL. Interviews were transcribed and analyzed using a grounded coding schema, with key barriers and recommendations mapped onto the Taplin Multi-Level Intervention model to help identify influences across various levels. Thirty-two CHAs participated, predominantly female (94%) and Black or African American (94%). At the individual level, factors involved demographic characteristics, increased patient workload, and attitudes towards technology. Social support was captured at the relationships level. At the provider level, provider–patient communication and injustices were involved, compounded by health system infrastructure and culture at the practice-setting level. Resource landscape and shared knowledge and beliefs were significant at the community level. The COVID-19 pandemic further highlighted these challenges at the societal level. CHAs provided targeted recommendations for addressing barriers at each level. CHAs identified multi-level factors contributing to DHL and emphasized levels based on comprehensive interventions.


  • Open Access

    Engagement Among Diverse Patient Backgrounds in a Remote Symptom Monitoring Program

    by Gabrielle B. Rocque, Nicole E. Caston, Keyonsis Hildreth, Luqin Deng, Nicole L. Henderson, Courtney P. Williams, Andres Azuero, Bradford E. Jackson, Jeffrey A. Franks, Chelsea McGowan, et al.

    PURPOSE: Previous randomized controlled trials have demonstrated benefit from remote symptom monitoring (RSM) with electronic patient-reported outcomes. However, the racial diversity of enrolled patients was low and did not reflect the real-world racial proportions for individuals with cancer. METHODS: This secondary, cross-sectional analysis evaluated engagement of patients with cancer in a RSM program. Patient-reported race was grouped as Black, Other, or White. Patient address was used to map patient residence to determine rurality using Rural-Urban Commuting Area Codes and neighborhood disadvantage using Area Deprivation Index. Key outcomes included (1) being approached for RSM enrollment, (2) declining enrollment, (3) adherence with RSM via continuous completion of symptom surveys, and (4) withdrawal from RSM participation. Risk ratios (RR) and 95% CI were estimated from modified Poisson models with robust SEs. RESULTS: Between May 2021 and May 2023, 883 patients were approached to participate, of which 56 (6%) declined RSM. Of those who enrolled in RSM, a total of 27% of patients were Black or African American and 67% were White. In adjusted models, all patient population subgroups of interest had similar likelihoods of being approached for RSM participation; however, Black or African American patients were more than 3× more likely to decline participation than White participants (RR, 3.09 [95% CI, 1.73 to 5.53]). Patients living in more disadvantaged neighborhoods were less likely to decline (RR, 0.49 [95% CI, 0.24 to 1.02]), but less likely to adhere to surveys (RR, 0.81 [95% CI, 0.68 to 0.97]). All patient populations had a similar likelihood of withdrawing. CONCLUSION: Black patients and individuals living in more disadvantaged neighborhoods are at risk for lower engagement in RSM. Further work is needed to identify and overcome barriers to equitable participation.


  • Open Access

    Patient-Perceived Benefits and Limitations of Standard of Care Remote Symptom Monitoring During Cancer Treatment

    by Catherine S. Smith, Nicole L. Henderson, Emma K. Hendrix, Tanvi Padalkar, Chao-Hui Sylvia Huang, D’aMbra N. Dent, Stacey A. Ingram, Chelsea McGowan, J. Nicholas Odom, Tara Kaufmann, et al.

    Introduction: Remote symptom monitoring (RSM) allows patients to electronically self-report symptoms to their healthcare team for individual management. Clinical trials have demonstrated overarching benefits; however, little is known regarding patient-perceived benefits and limitations of RSM programs used during patient care. Methods: This prospective qualitative study from December 2021 to May 2023 included patients with cancer participating in standard-of-care RSM at the University of Alabama at Birmingham (UAB) in Birmingham, AL, and the Univeristy of South Alabama (USA) Health Mitchell Cancer Institute (MCI) in Mobile, AL. Semi-structured interviews focused on patient experiences with and perceptions surrounding RSM participation. Interviews occurred over the phone, via digital videoconference, or in person, at the convenience of the patient. Grounded theory was used to conduct content coding and identify recurring themes and exemplary quotes using NVivo. Results: Forty patients (20 UAB, 20 MCI) were interviewed. Participants were predominately female (87.5%), aged 41-65 (50%), and married (57.5%). Data is consistent with local demographics, comprising mainly White (72.5%) and 27.5% Black individuals. Three main themes emerged regarding perceived benefits of RSM: (1) Facilitation of Proactive Management , identifying the patient’s needs and intervening earlier to alleviate symptom burden; (2) Promotion of Symptom Self-Management , providing patients autonomy in their cancer care; and (3) Improvement in Patient-Healthcare Provider Relationships , fostering genuine connections based on healthcare team’s responses. However, participants also noted Perceived Limitations of RSM ; particularly when support of symptom management was unnecessary, ineffective, or felt impersonal. Conclusion: This study focused on patient experiences when utilizing a RSM program while undergoing treatment for cancer and found benefits to its implementation that extended beyond symptom management. At the same time, patients noted drawbacks experienced during RSM, which can help with future tailoring of RSM programs. Patient perceptions should be regularly assessed and highlighted for successful and sustained implementation.


  • Symptom trajectory for patients utilizing remote symptom monitoring during gastrointestinal cancer treatment.

    by Bryanna Diaz, Chelsea McGowen, Nicole E. Caston, Sheila McElhany, Carrie C McNair, Naden Kreitz, Jeffrey Franks, Courtney J. Andrews, Chao-Hui Sylvia Huang, James Nicholas Odom, et al.

    345 Background: Use of electronic patient-reported outcome data allows patients to report symptoms in real time. This analysis aims to better understand the trajectory for symptoms reported via Remote Symptom Monitoring (RSM) by patients receiving gastrointestinal (GI) cancer treatment. Methods: This retrospective cohort study included patients initiating GI cancer treatment (chemotherapy, targeted therapy, and immunotherapy) between August 2022 and April 2023 at USA Health Mitchell Cancer Institute (MCI). Patients were eligible if they were starting a new treatment or had started treatment in the past 30 days. Patients received a weekly symptom survey over the course of 24 weeks through text message or e-mail. Patients were monitored for a total of 24 weeks regardless of their enrollment date. Patients reported symptoms as mild, moderate, severe, or very severe. All moderate and severe alerts were sent to the clinical nurse via the electronic medical record (EMR) to be acknowledged. After enrollment, health information including age, race, sex, zip code, ethnicity, cancer type, and cancer stage were extracted from the EMR. Descriptive statistics were calculated to examine frequencies of reported symptoms and their severity over time. Results: Of 75 GI patients approached, 63 patients (84%) were enrolled in RSM; 44% were female; 30% of patients were Black or African American, and median age was 65 (range 30-82). GI cancer types varied; Pancreatic (21%), Rectal (13%), Colorectal (14%), Colon (13%), Gastric (11%), Liver (11%), and other (17%). Over 24 weeks, 424 alerts were reported. Pain (31%), nausea and vomiting (21%), and decreased appetite (17%) were the most reported symptoms. 311 alerts were moderate (73%) and 113 were severe (27%). At week 0 (baseline; n = 63) 37 moderate alerts and 21 severe alerts were reported. At week 24 (final week; n = 63) 7 moderate alerts and 6 severe alerts were reported. Overall, there was a decreasing trajectory from week to week for moderate and severe alerts, with outliers noted at weeks 8 and 20. Conclusions: Findings suggest that RSM allows for an improvement in symptom trajectory for GI cancer patients based on the decrease in moderate and severe alerts reported from baseline to week 24. This decrease suggests that reported symptoms are being appropriately monitored and addressed by the patient's clinical care team due to improvement of symptoms or improvement of symptom management. Future research is needed to determine the benefits of prolonged RSM utilization by patient-reported quality of life as well as survival rate.

  • Symptom alert by type and severity among cancer patients using electronic patient reported outcomes for remote symptom monitoring.

    by Carrie C McNair, Chelsea McGowen, Nicole E. Caston, Sheila McElhany, Bryanna Diaz, Naden Kreitz, Jeffrey Franks, Courtney J. Andrews, Chao-Hui Sylvia Huang, James Nicholas Odom, et al.

    340 Background: Remote symptom monitoring (RSM) by electronic patient-reported outcomes (ePRO) data can elicit actionable symptoms from patients with cancer. However, patients with different cancer diagnoses are likely to have differing symptom profiles and variability in symptom alerts. To understand potential workflow needs, this analysis was conducted to determine which types of symptoms and severity of alerts can be expected based on cancer type. Methods: Cancer patients initiating chemotherapy, immunotherapy, or targeted therapy at 2 academic cancer centers in Alabama, UAB O’Neal Comprehensive Cancer Center and USA Health Mitchell Cancer Institute (MCI), were enrolled in ePRO-based RSM. Site rollouts were differential: UAB enrolled by disease group starting May 2021, MCI by provider starting July 2021. Patients received weekly symptom surveys of selected PRO-CTCAE questions through the Carevive ePRO mobile platform (PROmpt), triggering alerts to clinical teams if reported symptoms were determined to be moderate or severe. Demographics, cancer diagnosis, and ePRO data were extracted from electronic health records and Carevive. Descriptive statistics of categorical variables were calculated by frequencies and percentages; Cramer’s V and Cohen’s d were used for associations and effect size. Results: UAB enrolled 598 patients and MCI enrolled 274 patients by April 2023, consistent with the patient volume difference of the centers. 68% of enrollees were White; MCI saw a moderately higher % of Black patients (V: 0.21). 67% of enrolled patients were female. Median age was 61 years (Interquartile range: 51-69); UAB patients were slightly younger (d: 0.15). Among 872 enrolled patients, 9765 symptom alerts were generated. There was a small effect of cancer type on the overall type of symptoms and symptom severity reported (V: 0.11 and 0.09 respectively). Of the total number of symptom alerts, 28.0% of the alerts generated were for pain, followed by nausea/vomiting (14.9%), and constipation (11.7%). When broken down by cancer type, pain was the symptom most frequently reported for each type. The next most frequently reported symptoms differed but were as expected by cancer type: coughing/dyspnea by lung cancer patients (20.6%); urinary complaints in genitourinary cancers (14.1%); and nausea/vomiting in gastrointestinal cancers (18.0%). The frequency of moderate alerts was 62.1%, varying from 34.0% in sarcoma to 66.6% in gastrointestinal cancers. 31.1% of the alerts were severe; sarcoma had the most severe alerts (56.0%) and hematologic had the least (27.1%). Conclusions: Across patients with differing cancer types, pain and gastrointestinal issues were over half the reported symptoms. However, variability by cancer diagnosis in both symptom type and severity was observed, suggesting the remote symptom management workload for providers may vary by cancer type.